Skip to content
10-K

Annual Report

American Oncology Network, Inc.

0001839998-24-000021

← back to feed
Filed
Mar 28, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2023 · Dec 31, 2022 0 sh
Shares Diluted FY 2023 · Dec 31, 2021 0 sh
Stock Repurchased FY 2023 · Dec 31, 2022 $0
Stock Repurchased FY 2023 · Dec 31, 2021 $0
Capex FY 2023 · Dec 31, 2022 $7.19M
Capex FY 2023 · Dec 31, 2021 $8.32M
Operating Cash Flow restated FY 2023 · Dec 31, 2022 −$6.78M
Operating Cash Flow restated FY 2023 · Dec 31, 2021 −$26.34M
Long Term Debt FY 2023 · Dec 31, 2022 $80.3M
Cash And Equivalents restated FY 2023 · Dec 31, 2022 $26.93M
Current Liabilities restated FY 2023 · Dec 31, 2022 $140.94M
Total Liabilities restated FY 2023 · Dec 31, 2022 $264.21M
Current Assets restated FY 2023 · Dec 31, 2022 $242.02M
Total Assets restated FY 2023 · Dec 31, 2022 $326.23M
Eps Diluted FY 2023 · Dec 31, 2022 $0.00
Eps Diluted FY 2023 · Dec 31, 2021 $0.00
Eps Basic FY 2023 · Dec 31, 2022 $0.00
Eps Basic FY 2023 · Dec 31, 2021 $0.00
Sga Expense FY 2023 · Dec 31, 2022 $86.61M
Sga Expense FY 2023 · Dec 31, 2021 $77.05M
Operating Income restated FY 2023 · Dec 31, 2022 $5.57M
Operating Income restated FY 2023 · Dec 31, 2021 $911K
Cost Of Revenue FY 2023 · Dec 31, 2022 $1.05B
Cost Of Revenue FY 2023 · Dec 31, 2021 $865.79M
Revenue FY 2023 · Dec 31, 2022 $1.15B
Revenue FY 2023 · Dec 31, 2021 $943.75M